Ayana bio announces appointment of frank jaksch as chief executive officer

Health and wellness industry veteran will lead the company to scale sustainable bioactives using plant cell technology instead of agriculture                                                      boston , aug. 24, 2022 /prnewswire/ -- ayana bio, the plant cell technology company making sustainable bioactives for consumer products, today announced the appointment of frank jaksch as the company's chief executive officer. jaksch founded, was the longtime ceo and presently serves as board chair of health and wellness company chromadex, manufacturer of popular nad product, tru niagen (nasdaq: cdxc).
DNA Ratings Summary
DNA Quant Ranking